Company Overview
- Headquarters
- 6714 NW 16th St, Gainesville FL
- Website
- cyclotherapeutics.com
- Phone
- (386) 418-8060
- Employees
- 19
- Founded in
- 1990
- Industry
- Materials/Manufacturing
- NAICS Code
-
NAICS Code 54 CompaniesNAICS Code 32541 CompaniesNAICS Code 32 CompaniesNAICS Code 3254 CompaniesNAICS Code 325 CompaniesNAICS Code 541 Companies
- SIC Code
-
SIC Code 28 CompaniesSIC Code 873 CompaniesSIC Code 87 CompaniesSIC Code 283 Companies
Financials & Stats
Revenue
$1B
Who is Cyclo Therapeutics Inc
Cyclo Therapeutics Inc. is a clinical-stage biotechnology company headquartered in Gainesville, Florida. The company employs 19 people and has generated $1 million in revenue. Cyclo Therapeutics focuses on developing innovative medicines for patients with diseases. Their lead product, Trappsol® Cyclo™, is an orphan drug designated for the treatment of Niemann-Pick Disease Type C, a rare and fatal genetic disorder. The company is conducting multiple clinical trials for this indication, including Phase 2b trials for early Alzheimer's disease. Trappsol® Cyclo™ is also being investigated for other potential applications. Encouraging data from an Expanded Access program for Alzheimer's disease has led to the initiation of a Phase 2b clinical trial using the drug intravenously. For more information about Cyclo Therapeutics Inc. and their groundbreaking research, visit their website at www.cyclotherapeutics.com.
Company Leadership
Cyclo Therapeutics Inc Industry Tags
Cyclo Therapeutics Inc Tech Stack
Companies Similar to Cyclo Therapeutics Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Cyclo Therapeutics Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 1M | 9 | Waltham, MA | 2007 | |
| 1M | 4 | |||
| 1M | 93 | Princeton, NJ | 1993 | |
| 1M | 4 | |||
| 1M | 3 | California, CA |